BACC: Protocol for Rapid Diagnosis of Myocardial Infraction

The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe.

To carry out the BACC study (Biomarkers in Acute Cardiovascular Care) the effects of the troponin assay at 1 hour were compared to its effects after the 3 hours recommended by the ESC guidelines in 1.045 patients presenting with acute chest pain (mean age 65, 64.9% male). In addition, they analyzed a cut off value of 6 ng/L, far lower than the recommended 27 ng/L 99th percentile value for the ultrasensitive troponin assay (Elecsys; Roche Diagnostics) and the high sensitivity troponin I assay (STAT hs Tn I; Abbott Diagnostics).

The use of ultrasensitive cTn I with a ≤ 6 ng/L cutoff ruled out STEMI in 402 patients after an hour, and no differences were observed when compared to discharge at 3 hours. Moreover, compared to the 6 ng/L, the 27 ng/L cutoff resulted in a lower negative predictive value (NPV), regardless testing time (P < .005 for both) and also resulted in lower sensitivity.

An algorithm to rule out NSTEMI should include the ultrasensitive cTn I > 6 ng/L after one hour with a 12 ng/L delta compared to admission values (positive predictive value PPV 87.1%; specificity 98.0%).

These algorithms were verified against 4.009 patients from the European cohort (NPV 99.2% rule out, PPV 80.4% rule in) that also used a 1 hour algorithm, and against the Australian cohort (NPV 99.7% rule out; VPP 81.5% rule in).

During a 183 day follow up, only 3 patients died (0.79%) in the rule out < 6 ng/L group. However, 12 had died (1.73%) using the 27 ng/L cut off value (P < .05).

Westermann D.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...